Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Oct 14, 2014 · 10-K · 106 days after period end · 0001144204-14-060984
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$217.59K | -$224.53K | -$2.55M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Oct 14, 2014 · 106 d after period end
